Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

The risk of developing multiple sclerosis in individuals seronegative for Epstein-Barr virus: a meta-analysis.
Fingolimod reduces recurrence of disease activity after natalizumab withdrawal in multiple sclerosis.
Chronic cerebrospinal venous insufficiency: Case-control neurosonography results.
Multiple Sclerosis: Validation of MR Imaging for Quantification and Detection of Iron.
Biomarkers in multiple sclerosis.
Elevated melatonin levels in natalizumab-treated female patients with relapsing-remitting multiple sclerosis: Relationship to oxidative stress.
Role of statins in the treatment of multiple sclerosis.
Spatiotemporal distribution of white matter lesions in relapsing-remitting and secondary progressive multiple sclerosis.
Evaluation of a multiparametric immunofluorescence assay for standardization of neuromyelitis optica serology.
The cytokines cardiotrophin-like cytokine/cytokine-like factor-1 (CLC/CLF) and ciliary neurotrophic factor (CNTF) differ in their receptor specificities.
IL-1β induces hypomyelination in the periventricular white matter through inhibition of oligodendrocyte progenitor cell maturation via FYN/MEK/ERK signaling pathway in septic neonatal rats.
An Empirical Investigation of a Biopsychosocial Model of Pain in Multiple Sclerosis.
Multiple sclerosis remission following antiretroviral therapy in an HIV-infected man.
Lack of confirmation of anti-inward rectifying potassium channel 4.1 antibodies as reliable markers of multiple sclerosis.
Inflammatory Response and Chemokine Expression in the White Matter Corpus Callosum and Gray Matter Cortex Region During Cuprizone-Induced Demyelination.
Huperzine A ameliorates experimental autoimmune encephalomyelitis via the suppression of T cell-mediated neuronal inflammation in mice.
Autoinflammatory grey matter lesions in humans: cortical encephalitis, clinical disorders, experimental models.
Investigational Laquinimod Demonstrates Its Potential as a New Oral Treatment For RRMS
Epistasis and immunity: the role of genetic interactions in autoimmune diseases.
Association between multiple sclerosis and chronic periodontitis: a population-based pilot study.
Daphnetin Alleviates Experimental Autoimmune Encephalomyelitis via Regulating Dendritic Cell Activity.
Multiple sclerosis: a primary care perspective.
Listeria Meningitis Complicating Alemtuzumab Treatment in Multiple Sclerosis-Report of Two Cases.
No increase in cancer incidence detected after cyclophosphamide in a French cohort of patients with progressive multiple sclerosis.
Placebo power.

Pages